IL6 and interstitial lung disease: In systemic sclerosis-ILD, IL-6 directly activates fibroblasts via JAK/STAT3 signaling, promoting type I collagen synthesis, myofibroblast differentiation, resistance to apoptosis, and reduced MMP-mediated collagen degradation [158,194].